I agree BG but 16 years of non performance is very hard to digest and it shows, in fact
regardless yesterday's two ann could be seen positive (still with too many "if & but")
market was very cautious. Now let's see if Diamond's ability to delegate will make the most out
of this new situation for the benefit of ANP and of course shareholders and hopefully
will not end to the usual endless.........
Now next should be the publication of the manuscript and JV for ATL1103
- Forums
- ASX - By Stock
- PER
- News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review
News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-7
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.0¢ | $47.27K | 463.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 319942 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 86442 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 319942 | 0.100 |
3 | 113179 | 0.099 |
1 | 13000 | 0.098 |
2 | 130927 | 0.097 |
1 | 10004 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 86442 | 3 |
0.110 | 290000 | 4 |
0.115 | 601850 | 5 |
0.120 | 275642 | 8 |
0.125 | 65000 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |